UP.AIACT.IN
![[and more...] (3).png](https://static.wixstatic.com/media/f0525d_a8e80b852d194395a9eebf462f119e10~mv2.png/v1/crop/x_46,y_517,w_3104,h_1725/fill/w_980,h_545,al_c,q_90,usm_0.66_1.00_0.01,enc_avif,quality_auto/%5Band%20more___%5D%20(3).png)
28 Stakeholders. 4 Editors. 10 Sectors. 1 Uttar Pradesh.

India's first AI Transformation Report and Matrix on the State of Uttar Pradesh, India
The AI Transformation Matrix: Problem Statements
Powered by AIACT.IN, the matrix offers a consolidated version of 77 distinct recommendations in the form of "Sectoral Playbooks" from the UP.AIACT.IN Report 2026.
Sector
Hospital Infrastructure, Advanced Pharmaceuticals
Sectoral Sub-issue
Clinical Infrastructure and Patient Cohort Matching
Problem Statement
- State capital expenditure is routinely diluted into general hospital IT, leaving the state without physically separate infrastructure for advanced clinical trials and creating massive bottlenecks in identifying eligible patient cohorts.
AI Intervention Layer, defined*
*India's IT Minister once said there are 5 layers of AI (there could be more or less). Hence it becomes necessary to define which specific AI layer was targeted in our policy recommendation for this problem statement.​
- Deployment of AI data extraction pipelines and automated cohort matching algorithms over unified, anonymized EMR databases.
Here's what we Recommend.
- Earmark funds exclusively to construct physically separate, dedicated clinical trial wards within high footfall institutions like KGMU, SGPGIMS, and BHU IMS. Systematically deploy AI driven data extraction and anonymization tools across the Electronic Medical Records (EMRs) of state medical colleges.
Possible Mandate Recommended for the Uttar Pradesh State Government
- The administration must prohibit the dilution of state capital expenditure into generic healthcare IT, mandating instead the deployment of algorithmic matching tools to parse complex trial criteria against strictly anonymized patient datasets.
Measurable Impact of our Recommendations
- Global pharma companies secure instantaneous identification of viable cohorts and seamless access to compliant Phase II and III infrastructure without placing additional burdens on standard public healthcare operations.
Possible risks
- Allowing clinical research funding to be consumed by general hospital IT upgrades, or failing to deploy proper EMR anonymization protocols which compromises data safety.
Possible Economic Spillover of the Policy Move
- Directly transforms the unprecedented demographic scale of Uttar Pradesh into a highly monetizable, data driven asset for the global life sciences ecosystem.
AI Policy Severity Index*
*Derived directly from the 77 foundational structural challenges evaluated across ten industries within the UP.AIACT.IN Report, the AI Policy Severity Index functions as an evidence-based diagnostic tool designed to classify grassroots operational friction that emerges prior to the rollout of artificial intelligence systems.
Primary Severity Level
- Level 3: Technical & Data Infrastructure Bottleneck
Secondary Severity Level
Primary Stakeholder Group
Technical Architects & Systems Engineers, Executive & Policy Decision-Makers
Stakeholder Hierarchy
Tactical & Operational Management Layer
In which Chapter of the UP.AIACT.IN Report 2026 can you find this recommendation?
Chapter 8
Level 3: Technical & Data Infrastructure Bottleneck